EW Stock Summary and Trading Ideas (Edwards Lifesciences | NYSE:EW)

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.

Edwards Lifesciences trades on the NYSE stock market under the symbol EW.

As of April 24, 2024, EW stock price climbed to $88.61 with 2,357,992 million shares trading.

EW has a beta of 1.69, meaning it tends to be more sensitive to market movements. EW has a correlation of 0.34 to the broad based SPY ETF.

EW has a market cap of $53.34 billion. This is considered a Large Cap stock.

Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.64 earnings per share. This beat revenue expectation by $44 million and met earnings estimates .

In the last 3 years, EW stock traded as high as $131.73 and as low as $60.57.

The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, SPY, IVV, VUG.

EW has underperformed the market in the last year with a price return of +2.4% while the SPY ETF gained +24.2%. However, in the short term, EW had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.4% vs +4.6% return in SPY. But in the last 2 weeks, EW shares have been beat by the market, returning -4.8% compared to an SPY return of -2.7%.

EW support price is $86.42 and resistance is $89.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW stock will trade within this expected range on the day.